Ultragenyx Pharmaceutical
RARE
#3777
Rank
โ‚น300.82 B
Marketcap
โ‚น3,118
Share price
3.73%
Change (1 day)
-16.33%
Change (1 year)

EPS for Ultragenyx Pharmaceutical (RARE)

EPS in 2025 (TTM): -โ‚น514.52

According to Ultragenyx Pharmaceutical's latest financial reports the company's current EPS (TTM) is -โ‚น533.00. In 2024 the company made an earnings per share (EPS) of -โ‚น568.89 an increase over its 2023 EPS that were of -โ‚น747.45.

EPS history for Ultragenyx Pharmaceutical from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น514.52-9.56%
2024-โ‚น568.89-23.89%
2023-โ‚น747.45-17.61%
2022-โ‚น907.1750.67%
2021-โ‚น602.09113.69%
2020-โ‚น281.75-55.9%
2019-โ‚น638.8882.56%
2018-โ‚น349.95-45.15%
2017-โ‚น637.9814.68%
2016-โ‚น556.33
2014-โ‚น208.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
BioMarin Pharmaceutical
BMRN
โ‚น244.07-145.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-โ‚น9.87-98.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น44.87-91.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-โ‚น17.05-96.80%๐Ÿ‡บ๐Ÿ‡ธ USA